Share the Video:

Ketamine Reality Check: Miracle, Mirage, or Misused?

PS2025 Ketamine

Hamilton Morris, Liana Gillooly, Gita Vaid

Ketamine has surged to the forefront of psychedelic medicine and pop culture alike—celebrated for its rapid antidepressant effects, versatile applications, and unique pharmacology. But alongside the accolades is a growing shadow: rising recreational misuse, dependency risks, and a booming industry often more focused on profit than care. In this candid fireside chat, Hamilton Morris brings his deep expertise and divergent perspectives to a necessary reality check. Together, they will explore ketamine’s legitimate healing potential, the culture that has grown around it, and the urgent need for ethical, grounded frameworks in both clinical and underground settings. This session aims to spark honest dialogue and reorient the field toward integrity, nuance, and responsibility.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Surviving NXIVM, cults, and sexual violence: A story of abuse, healing, and ketamine-assisted therapy retreats

Catherine Oxenberg's daughter India survived a traumatic experience in the NXIVM cult, leading to long-lasting scars. The Catherine Oxenberg Foundation now supports survivors of sexual assault with ketamine-assisted psychotherapy retreats.

Vicky Dulai, Catherine Oxenberg, India Oxenberg

PS2023 Depression Ketamine Research and Science

Toward “next generation” ketamine treatment: from new insights into the neurobiology of depression to strategies to optimize ketamine efficacy

Dr. Ronald Duman and George Aghajanian's research on ketamine's effects on depression led to further studies on glutamate signaling and synaptic density restoration. Combining ketamine with psychotherapy or MTORC1 inhibitors

John H Krystal

PS2023 Depression Health Conditions Ketamine Psychedelic Assisted Therapy Psychedelic Science Research and Science

A trial of ketamine masked by surgical anesthesia in depressed patients

Ketamine and other psychedelics show promise for psychiatric disorders, but their psychoactive effects complicate masking in trials. A triple-masked trial on 40 patients with depression found surprising results.

Boris D. Heifets

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Science Research and Science Substance Use Disorder

The Mirror Molecule: How can ketamine and other substances be both addictive and anti-addictive?

Ketamine and psilocybin show promise for health conditions but come with risks, including addiction. This talk challenges the view of drugs as neutral tools and explores their complex nature and

Elias Dakwar

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Assisted Therapy Research and Science Therapy Ethics

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses

KAP program offers innovative treatment for adolescents with emotional issues, focusing on family involvement. Successes and challenges of this unique approach are discussed.

Phil Wolfson

PS2023 Depression Indigenous People Ketamine Plant Medicine Psychedelic Assisted Therapy Research and Science

Considering psychedelic therapy for adolescents

Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines

Corine de Boer, Rebecca Kronman, Glauber Assis

PS2023 Ketamine MDMA Psilocybin Psychedelic Assisted Therapy Psychedelic Science Research

Psychedelics as The Great Disrupters: Reconstructing the Future of Mental Healthcare

Dr. Ben Sessa will discuss similarities among MDMA, ketamine, and psilocybin in clinical settings, exploring their potential in treating trauma-based disorders and challenges in psychedelic medicalization.

Ben Sessa

PS2023 Business Ketamine Policy Research and Science Resources for Therapists

Ketamine Treatment: Current Issues and Controversies

Dr. Bennett explores the expanding field of ketamine treatment, covering current trends, controversies, and potential topics like enantiomers, mail order platforms, provider training, economics, and FDA approval challenges.

PS2023 Depression Harm Reduction Ketamine Mental Health Psychedelic Assisted Therapy Research and Science

Panel discussion: The state of ketamine-assisted therapy

Ketamine, a WHO essential medicine, has long been used globally as an anesthetic. Its off-label use for depression is growing, sparking discussions on efficacy, safety, and regulation.

Raquel Bennet, Sunny Strasburg, Gita Vaid, Danielle M Herrera, Lauren Taus

Ketamine Reality Check: Miracle, Mirage, or Misused?

Become a MAPS Member with a monthly donation

Related Videos